Latest stories
Featured
Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic®...
Press Release, Business Development 12 February 2024
- Hikma launches Furosemide Injection, USP, in the US Press Release, Product 09 December 2024 Hikma launches Furosemide Injection, USP, in the US
- Sell-side analysts and investors visit Hikma Casablanca site Press Release, Corporate 14 November 2024 Sell-side analysts and investors visit Hikma Casablanca site
- Celebrating Global Biosimilars Week: Hikma champions access to essential medicines for patients in the MENA region Story, Business Development 12 November 2024 Celebrating Global Biosimilars Week: Hikma champions access to essential medicines for patients in the MENA region
- Hikma continues strong strategic execution and reiterates guidance Press Release, Financial Results 07 November 2024 Hikma continues strong strategic execution and reiterates guidance
Related content